Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Arthritis, Rheumatoid × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 22 Breast Neoplasms 14 Neoplasms 12 Myelodysplastic Syndromes 11 Prostatic Neoplasms 10 Multiple Myeloma 8 Lung Neoplasms 7 Stomach Neoplasms 6 Sarcoma 6 Ovarian Neoplasms 5 Leukemia, Myelomonocytic, Chronic 5 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Solid Tumor 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Solid Tumor 3 Recurrence 3 Primary Myelofibrosis 3 Pain 3 Myeloproliferative Disorders 3 Mucositis 3 Lymphoma, T-Cell, Peripheral 3 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Thrombocythemia, Essential 2 Stomatitis 2

Interventions

Adalimumab 13 Etanercept 8 Methotrexate 7 Rituximab 6 Abatacept 6 tocilizumab 5 golimumab 5 tofacitinib 4 olokizumab 4 Certolizumab Pegol 4 Tumor Necrosis Factor Inhibitors 3 Infliximab 3 Saline Solution 2 Antirheumatic Agents 2 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 baricitinib 1 Vitamin D 1 Vaccines 1 TACI receptor-IgG Fc fragment fusion protein 1 Syringes 1 Sulfasalazine 1 Sodium Chloride 1 Radioimmunodetection 1 RC-18 1 Pharmaceutical Preparations 1 Lysine Acetyltransferase 5 1 Leflunomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05090124 2025-01-14

REALISE

NHS Greater Glasgow and Clyde

Phase NA Completed

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡